1. Applications of Recombinant Adenovirus-p53 Gene Therapy for Cancers in the Clinic in China
   Yu Xia et al, 2020, Current Gene Therapy CrossRef
2. Oncolytic virus combined with traditional treatment versus traditional treatment alone in patients with cancer: a meta-analysis
   Yuwei Li et al, 2020, International Journal of Clinical Oncology CrossRef
3. Targeted Gene Delivery Therapies for Cervical Cancer
   Ángela Áyen et al, 2020, Cancers CrossRef
4. An evidence map of randomised controlled trials evaluating genetic therapies
   Eric A. Apaydin et al, 2021, BMJ Evidence-Based Medicine CrossRef
5. Immunotherapy in Cervical and Endometrial Cancer: Current Landscape and Future Directions
   Dimitrios Stefanoudakis et al, 2024, Life CrossRef
6. Therapeutic vaccines and immune checkpoints inhibition options for gynecological cancers
   Chiara Di Tucci et al, 2018, Critical Reviews in Oncology/Hematology CrossRef
7. Immunohistochemical WWOX Expression and Association with Angiogenesis, p53 Expression, Cell Proliferation and Clinicopathological Parameters in Cervical Cancer
   Mariana Ataydes Leite Seabra et al, 2018, Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics CrossRef
8. Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy
   Bin Song et al, 2024, Cancer Communications CrossRef
9. Therapeutic potential of p53 reactivation in cervical cancer
   Xiangxuan Zhao et al, 2021, Critical Reviews in Oncology/Hematology CrossRef
10. Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes
    Alexander Malogolovkin et al, 2021, Viruses CrossRef
11. Head and Neck Cancer Research and Support Foundations
    Joshua E. Lubek, 2018, Oral and Maxillofacial Surgery Clinics of North America CrossRef
12. Improving adenoviral vectors and strategies for prostate cancer gene therapy
    Rodrigo Esaki Tamura et al, 2018, Clinics CrossRef
13. Understanding the prion-like behavior of mutant p53 proteins in triple-negative breast cancer pathogenesis: The current therapeutic strategies and future directions
    Yasaman Naeimzadeh et al, 2024, Heliyon CrossRef
14. Hyperactivating p53 in Human Papillomavirus-Driven Cancers: A Potential Therapeutic Intervention
    Yusuf M. Idres et al, 2022, Molecular Diagnosis & Therapy CrossRef
15. Virus against virus: strategies for using adenovirus vectors in the treatment of HPV-induced cervical cancer
    Momeneh Ghanaat et al, 2021, Acta Pharmacologica Sinica CrossRef
16. Recombinant Human Adenovirus-p53 Therapy for the Treatment of Cervical Cancer: A Meta-Analysis
    Yaru Guo et al, 2021, Frontiers in Oncology CrossRef
17. Cancer and HIV: The Molecular Mechanisms of the Deadly Duo
    Aadilah Omar et al, 2024, Cancers CrossRef